Singapore, June 4 -- ThinkCyte, a Japan-based life science company pioneering advanced artificial intelligence (AI)-powered cell analysis and sorting technologies, has announced the pre-commercial launch of MorphoScan Cloud, its new cloud-based platform designed for flexible data access, faster processing, and advanced AI-driven analysis.

MorphoScan Cloud expands the user experience for customers of VisionSort, ThinkCyte's flagship morphometric cell analysis and sorting platform. With secure cloud storage and multi-user access capabilities, MorphoScan Cloud enables research teams across geographies to centralise, share, and analyze VisionSort-generated data more efficiently.

With an integrated suite of advanced analytical tools, purpose...